Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurbinectedin and Olaparib in Advanced Solid Tumors
NCT02684318Phase 2Unknown
- Sponsor
- Andrés Poveda Oncología
- Start
- Jul 2015
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Phase 2, open-label trial of lurbinectedin in solid tumor, ovarian cancer, endometrial cancer (EC) and 1 more, sponsored by Andrés Poveda Oncología. Status: unknown.
02
Drugs
lurbinectedin
03
Conditions
solid tumorovarian cancerendometrial cancer (EC)breast cancer
Beyond the preview
Go deeper on NCT02684318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02684318.